{{Rsnum
|rsid=6070035
|Gene=BMP7
|Chromosome=20
|position=57250637
|Orientation=plus
|GMAF=0.4123
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BMP7
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 27.4 | 56.6 | 15.9
| HCB | 62.8 | 31.4 | 5.8
| JPT | 57.5 | 35.4 | 7.1
| YRI | 22.4 | 55.8 | 21.8
| ASW | 23.2 | 58.9 | 17.9
| CHB | 62.8 | 31.4 | 5.8
| CHD | 59.6 | 31.2 | 9.2
| GIH | 34.7 | 47.5 | 17.8
| LWK | 40.0 | 50.0 | 10.0
| MEX | 25.9 | 46.6 | 27.6
| MKK | 27.6 | 55.1 | 17.3
| TSI | 26.7 | 53.5 | 19.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs6070035
|Name_s=
|Gene_s=BMP7
|Feature=
|Evidence=PubMed ID:17537913
|Annotation=Risk or phenotype-associated allele: not stated Phenotype: Using a Quantitative Transmission Disequilibrium Test (QTDT), this variant was significantly associated with etoposide toxicity based upon IC50 values in cell lines from 30 parent-child trios. Study size: 87. Study population/ethnicity: 87 European descent Caucasians. Significance metric(s): p = 0.00002. Type of association: FA; GN.
|Drugs=etoposide
|Drug Classes=
|Diseases=Drug Toxicity
|Curation Level=Curated
|PharmGKB Accession ID=PA165109328
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6070035
|overall_frequency_n=30
|overall_frequency_d=80
|overall_frequency=0.375
|n_genomes=25
|n_genomes_annotated=0
|n_haplomes=30
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}